FDA Approves Unknown Drug — ZYDUS PHARMS
ZYDUS PHARMS has received FDA approval for an ANDA (ANDA206097), a move that strengthens its commercial portfolio and is expected to create a significant market opportunity for the company.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day